pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 3·1 min read
save

Neurologist Who Diagnoses ALS Patients Receives Own Diagnosis, Reflects on Impact of Disability

Aug 3, 2026·read at STAT ↗Negative

Dr. Christopher Campos, a neurologist and assistant professor at UC Davis Health, disclosed that he was diagnosed with amyotrophic lateral sclerosis (ALS) in 2025 after a decade of delivering the same diagnosis to patients.

He grew up in South Florida, became the first in his family to attend college, and built a career that included patient care, research, and an active personal life of cooking, swimming, yoga, and biking. In the fall of 2023 he first noticed weakness in his right hand, then his left, and a change in his voice.

Although his medical training let him recognize the warning signs, it still took two years before a formal ALS diagnosis was confirmed.

His experience on the opposite side of the conversation has taught him that society often equates physical dependence with diminished personhood, underscoring the need for greater empathy toward people living with progressive diseases.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: I’m a neurologist. I’ve delivered ALS diagnoses. Then I received one myself”

read at STAT ↗
1,215 words · retrieved Aug 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Traeger, Inc.
topics
ALS17CardiologyNeurologyType 2 Diabetes

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Sling reels in $123M; Circle gathers $92.5MFierce Biotech
  • 1d agoNovartis halts TREM2 targeting ALS program in 4th trial stumble in a monthBioSpace
  • Sep 4Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipelineFierce Biotech
  • Sep 3FDA approves Ionis’ antisense drug as first targeted therapy for Alexander diseaseBioSpace
  • Aug 4Opinion: How Josée became one of the 7.9% of Québécois who die by assisted suicideSTAT